371 related articles for article (PubMed ID: 25138370)
21. Association of rheumatoid factor and anti-cyclic citrullinated peptide positivity, but not carriage of shared epitope or PTPN22 susceptibility variants, with anti-tumour necrosis factor response in rheumatoid arthritis.
Potter C; Hyrich KL; Tracey A; Lunt M; Plant D; Symmons DP; Thomson W; Worthington J; Emery P; Morgan AW; Wilson AG; Isaacs J; Barton A;
Ann Rheum Dis; 2009 Jan; 68(1):69-74. PubMed ID: 18375541
[TBL] [Abstract][Full Text] [Related]
22. Association of anti-cyclic citrullinated peptide antibodies and rheumatoid factor isotypes with HLA-DRB1 shared epitope alleles in Egyptian rheumatoid arthritis patients.
Raslan HM; Attia HR; Hamed Ibrahim M; Mahmoud Hassan E; Salama II; Ismail S; Abdelmotaleb E; El Menyawi MM; Amr KS
Int J Rheum Dis; 2020 May; 23(5):647-653. PubMed ID: 32167241
[TBL] [Abstract][Full Text] [Related]
23. The PTPN22 1858C/T polymorphism is associated with anti-cyclic citrullinated peptide antibody-positive early rheumatoid arthritis in northern Sweden.
Kokkonen H; Johansson M; Innala L; Jidell E; Rantapää-Dahlqvist S
Arthritis Res Ther; 2007; 9(3):R56. PubMed ID: 17553139
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of the rheumatoid arthritis susceptibility loci HLA-DRB1, PTPN22, OLIG3/TNFAIP3, STAT4 and TRAF1/C5 in an inception cohort.
Morgan AW; Robinson JI; Conaghan PG; Martin SG; Hensor EM; Morgan MD; Steiner L; Erlich HA; Gooi HC; Barton A; Worthington J; Emery P; ;
Arthritis Res Ther; 2010; 12(2):R57. PubMed ID: 20353580
[TBL] [Abstract][Full Text] [Related]
25. Identification of anticitrullinated protein antibody reactivities in a subset of anti-CCP-negative rheumatoid arthritis: association with cigarette smoking and HLA-DRB1 'shared epitope' alleles.
Wagner CA; Sokolove J; Lahey LJ; Bengtsson C; Saevarsdottir S; Alfredsson L; Delanoy M; Lindstrom TM; Walker RP; Bromberg R; Chandra PE; Binder SR; Klareskog L; Robinson WH
Ann Rheum Dis; 2015 Mar; 74(3):579-86. PubMed ID: 24297382
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of functional haplotypes of the peptidylarginine deiminase citrullinating enzyme gene in patients with rheumatoid arthritis: no influence of the presence of anti-citrullinated peptide antibodies.
Faragó B; Talián GC; Maász A; Magyari L; Horvatovich K; Kovács B; Cserép V; Kisfali P; Kiss CG; Czirják L; Melegh B
Clin Exp Rheumatol; 2007; 25(4):523-8. PubMed ID: 17888206
[TBL] [Abstract][Full Text] [Related]
27. Polymorphisms and functional haplotype in PADI4: further evidence for contribution on rheumatoid arthritis susceptibility and anti-cyclic citrullinated peptide antibodies in a western Mexican population.
Guzmán-Guzmán IP; Reyes-Castillo Z; Muñoz-Barrios S; Ruiz-Noa Y; Martínez-Bonilla GE; Parra-Rojas I; Palafox-Sánchez CA; Muñoz-Valle JF
Immunol Lett; 2015 Feb; 163(2):214-20. PubMed ID: 25562673
[TBL] [Abstract][Full Text] [Related]
28. HLA-C alleles confer risk for anti-citrullinated peptide antibody-positive rheumatoid arthritis independent of HLA-DRB1 alleles.
Nordang GB; Flåm ST; Maehlen MT; Kvien TK; Viken MK; Lie BA
Rheumatology (Oxford); 2013 Nov; 52(11):1973-82. PubMed ID: 23901134
[TBL] [Abstract][Full Text] [Related]
29. Auto-antibodies, HLA and PTPN22: susceptibility markers for rheumatoid arthritis.
Orozco G; Pascual-Salcedo D; López-Nevot MA; Cobo T; Cabezón A; Martín-Mola E; Balsa A; Martín J
Rheumatology (Oxford); 2008 Feb; 47(2):138-41. PubMed ID: 18156150
[TBL] [Abstract][Full Text] [Related]
30. TRAF1-C5 as a risk locus for rheumatoid arthritis--a genomewide study.
Plenge RM; Seielstad M; Padyukov L; Lee AT; Remmers EF; Ding B; Liew A; Khalili H; Chandrasekaran A; Davies LR; Li W; Tan AK; Bonnard C; Ong RT; Thalamuthu A; Pettersson S; Liu C; Tian C; Chen WV; Carulli JP; Beckman EM; Altshuler D; Alfredsson L; Criswell LA; Amos CI; Seldin MF; Kastner DL; Klareskog L; Gregersen PK
N Engl J Med; 2007 Sep; 357(12):1199-209. PubMed ID: 17804836
[TBL] [Abstract][Full Text] [Related]
31. Anti-citrullinated glucose-6-phosphate isomerase peptide antibodies in patients with rheumatoid arthritis are associated with HLA-DRB1 shared epitope alleles and disease activity.
Umeda N; Matsumoto I; Ito I; Kawasaki A; Tanaka Y; Inoue A; Tsuboi H; Suzuki T; Hayashi T; Ito S; Tsuchiya N; Sumida T
Clin Exp Immunol; 2013 Apr; 172(1):44-53. PubMed ID: 23480184
[TBL] [Abstract][Full Text] [Related]
32. The role of eight polymorphisms in three candidate genes in determining the susceptibility, phenotype, and response to anti-TNF therapy in patients with rheumatoid arthritis.
Ceccarelli F; D'Alfonso S; Perricone C; Carlomagno Y; Alessandri C; Croia C; Barizzone N; Montecucco C; Galeazzi M; Sebastiani GD; Minisola G; Fiocco U; Valesini G
Clin Exp Rheumatol; 2012; 30(6):939-42. PubMed ID: 22992305
[TBL] [Abstract][Full Text] [Related]
33. HLA-DRB1 shared epitope alleles in patients with rheumatoid arthritis: relation to autoantibodies and disease severity in a south Indian population.
Konda Mohan V; Ganesan N; Gopalakrishnan R; Venkatesan V
Int J Rheum Dis; 2017 Oct; 20(10):1492-1498. PubMed ID: 27943654
[TBL] [Abstract][Full Text] [Related]
34. Specific Association of HLA-DRB1*03 With Anti-Carbamylated Protein Antibodies in Patients With Rheumatoid Arthritis.
Regueiro C; Rodriguez-Rodriguez L; Triguero-Martinez A; Nuño L; Castaño-Nuñez AL; Villalva A; Perez-Pampin E; Lopez-Golan Y; Abasolo L; Ortiz AM; Herranz E; Pascual-Salcedo D; Martínez-Feito A; Boveda MD; Gomez-Reino JJ; Martín J; Gonzalez-Escribano MF; Fernandez-Gutierrez B; Balsa A; Gonzalez-Alvaro I; Gonzalez A
Arthritis Rheumatol; 2019 Mar; 71(3):331-339. PubMed ID: 30277011
[TBL] [Abstract][Full Text] [Related]
35. Systematic approach demonstrates enrichment of multiple interactions between non-
Diaz-Gallo LM; Ramsköld D; Shchetynsky K; Folkersen L; Chemin K; Brynedal B; Uebe S; Okada Y; Alfredsson L; Klareskog L; Padyukov L
Ann Rheum Dis; 2018 Oct; 77(10):1454-1462. PubMed ID: 29967194
[TBL] [Abstract][Full Text] [Related]
36. Associations between serum anti-CCP antibody, rheumatoid factor levels and HLA-DR4 expression in Hungarian patients with rheumatoid arthritis.
Kapitány A; Szabó Z; Lakos G; Aleksza M; Végvári A; Soós L; Karányi Z; Sipka S; Szegedi G; Szekanecz Z
Isr Med Assoc J; 2008 Jan; 10(1):32-6. PubMed ID: 18300568
[TBL] [Abstract][Full Text] [Related]
37. Association of STAT4 rs7574865 and PTPN22 rs2476601 polymorphisms with rheumatoid arthritis and non-systemically reacting antibodies in Egyptian patients.
El-Lebedy D; Raslan H; Ibrahim A; Ashmawy I; El-Aziz SA; Mohammed AM
Clin Rheumatol; 2017 Sep; 36(9):1981-1987. PubMed ID: 28424905
[TBL] [Abstract][Full Text] [Related]
38. Interaction of HLA-DRB1*09:01 and *04:05 with smoking suggests distinctive mechanisms of rheumatoid arthritis susceptibility beyond the shared epitope.
Bang SY; Lee HS; Lee KW; Bae SC
J Rheumatol; 2013 Jul; 40(7):1054-62. PubMed ID: 23637323
[TBL] [Abstract][Full Text] [Related]
39. A spectrum of susceptibility to rheumatoid arthritis within HLA-DRB1: stratification by autoantibody status in a large UK population.
Mackie SL; Taylor JC; Martin SG; ; ; Wordsworth P; Steer S; Wilson AG; Worthington J; Emery P; Barrett JH; Morgan AW
Genes Immun; 2012 Feb; 13(2):120-8. PubMed ID: 21881596
[TBL] [Abstract][Full Text] [Related]
40. Influence of peptidylarginine deiminase type 4 genotype and shared epitope on clinical characteristics and autoantibody profile of rheumatoid arthritis.
Hoppe B; Häupl T; Egerer K; Gruber R; Kiesewetter H; Salama A; Burmester GR; Dörner T
Ann Rheum Dis; 2009 Jun; 68(6):898-903. PubMed ID: 18633125
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
